A Medical Research and Evaluation Facility and Studies Supporting the Medical Chemical Defense Program. A Comparison of the Biochemical Changes Produced by Vesicating and Non-Vesicating Alkylating Agents in Normal Human Epidermal Keratinocytes.
Abstract
Task 91-23 was conducted for the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) to compare alterations in selected biochemical endpoints using human epidermal keratinocytes (HEK) exposed in vitro to either non-vesicating (e.g., cisplatin) or vesicating (e.g., sulfur mustard; MD) alkylating agents. These data may provide insight into the biochemical mechanism(s) uniquely associated with tissue vesication. Preliminary in vivo experiments used three vesicating and three non-vesicating alkylating agents to confirm vesication potential by examining microblister formation in the hairless guinea pig (HGP). The three vesicating, alkylating agents selected were MD (positive control), mechlorethamine (nitrogen mustard; HN2), and chloroethylethyl sulfide (CEES). The three non-vesicating, alkylating agents selected were cisplatin, meiphalan, and thiotepa
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 1997
- Accession Number
- ADA322299
Entities
People
- Carl T. Olson
- Frances M. Reid
- James A. Blank
- John B. Johnson
- Ronald G. Menton
Organizations
- Battelle Memorial Institute